BEAMing sheds light on drug resistance

Josh Lauring, Ben Ho Park

Research output: Contribution to journalComment/debatepeer-review

Abstract

Targeted therapies against somatically altered genes are currently used for the treatment of many human cancers. The nascent technology known as BEAMing has the potential to increase the clinical utility of these agents because it allows for the detection of cancer mutations in peripheral blood, providing a rapid assessment of tumor mutation status.

Original languageEnglish (US)
Pages (from-to)7508-7510
Number of pages3
JournalClinical Cancer Research
Volume17
Issue number24
DOIs
StatePublished - Dec 15 2011
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'BEAMing sheds light on drug resistance'. Together they form a unique fingerprint.

Cite this